Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat

Dubreuil, P. ; Morisset, J.

Amsterdam : Elsevier
ISSN:
0167-0115
Keywords:
gastrin and duodenum growth ; hyperplasia ; somatocrinin ; somatostatin antiserum
Source:
Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
Topics:
Medicine
Type of Medium:
Electronic Resource
URL:
_version_ 1798291613358751746
autor Dubreuil, P.
Morisset, J.
autorsonst Dubreuil, P.
Morisset, J.
book_url http://linkinghub.elsevier.com/retrieve/pii/0167-0115(86)90194-1
datenlieferant nat_lic_papers
fussnote This study examines the effects of somatocrinin (GRF) and somatostatin antiserum (ASS), jointly and separately on gastric and duodenal growth. 24-day-old rats received twice daily SC injections of saline or GRF (4 and 20 μg . kg^-^1) for 14 days. ASS was given IP every 2 days. Alone, GRF increased gastric fundus weight concomitantly with DNA, RNA and protein contents producing hyperplasia and hypertrophy within this gland. Alone, ASS increased RNA and protein cellular concentrations. Joint ASS and GRF treatment stabilized the weight and protein content of the fundus, while reducing RNA contents as well as RNA and protein concentrations. GRF alone caused significant increments in duodenal weight and protein content suggesting cellular hypertrophy. Growth hormone, gastrin, cholecystokinin and secretin may be considered as putative mediators of these trophic effects.
hauptsatz hsatz_simple
identnr NLZ186759266
issn 0167-0115
journal_name Regulatory Peptides
materialart 1
package_name Elsevier
publikationsort Amsterdam
publisher Elsevier
reference 16 (1986), S. 51-67
schlagwort gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
search_space articles
shingle_author_1 Dubreuil, P.
Morisset, J.
shingle_author_2 Dubreuil, P.
Morisset, J.
shingle_author_3 Dubreuil, P.
Morisset, J.
shingle_author_4 Dubreuil, P.
Morisset, J.
shingle_catch_all_1 Dubreuil, P.
Morisset, J.
Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
0167-0115
01670115
Elsevier
shingle_catch_all_2 Dubreuil, P.
Morisset, J.
Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
0167-0115
01670115
Elsevier
shingle_catch_all_3 Dubreuil, P.
Morisset, J.
Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
0167-0115
01670115
Elsevier
shingle_catch_all_4 Dubreuil, P.
Morisset, J.
Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
gastrin and duodenum growth
hyperplasia
somatocrinin
somatostatin antiserum
0167-0115
01670115
Elsevier
shingle_title_1 Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
shingle_title_2 Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
shingle_title_3 Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
shingle_title_4 Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
timestamp 2024-05-06T08:35:23.926Z
titel Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
titel_suche Effect of somatocrinin and a somatostatin antiserum on duodenal and gastric growth in the rat
This study examines the effects of somatocrinin (GRF) and somatostatin antiserum (ASS), jointly and separately on gastric and duodenal growth. 24-day-old rats received twice daily SC injections of saline or GRF (4 and 20 μg . kg^-^1) for 14 days. ASS was given IP every 2 days. Alone, GRF increased gastric fundus weight concomitantly with DNA, RNA and protein contents producing hyperplasia and hypertrophy within this gland. Alone, ASS increased RNA and protein cellular concentrations. Joint ASS and GRF treatment stabilized the weight and protein content of the fundus, while reducing RNA contents as well as RNA and protein concentrations. GRF alone caused significant increments in duodenal weight and protein content suggesting cellular hypertrophy. Growth hormone, gastrin, cholecystokinin and secretin may be considered as putative mediators of these trophic effects.
topic WW-YZ
uid nat_lic_papers_NLZ186759266